International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

Recruiting

I'm Interested

Trial ID: NCT05363657

Purpose

Partial nephrectomy (PN) is the standard treatment for localized renal masses and should be preferred in clinical T1 (<7 cm tumor diameter) renal tumors over radical nephrectomy (RN) whenever technically feasible. Nonetheless, indications, approaches, techniques for PN, and correct reporting of outcomes, are still a matter of great debate within the urology community. Concurrently, case-report series suggested that alternative strategies for the treatment of localized renal tumors (ablation techniques (AT), watchful waiting (WW), active surveillance (AS)) could be feasible with acceptable oncologic outcomes in particular settings of patients with localized renal tumors. In this complex clinical scenario, the role surgeon-related and environmental factors (such as surgical experience, hospital resources, countries' social background and performance of health system) are important to address the best personalized approach in patients with renal tumors. In the light of current evidence, many unsolved questions still remain and many unmet needs must be addressed. In particular, 1) the risk-benefit trade-offs between PN and RN for anatomically complex renal localized tumors; 2) the definition of evidence-based strategies to tailor the management strategy (AT vs WW vs AS vs surgery) in different subset of patients with particular clinical conditions (i.e. old, frail, comorbid patients); and 3) the definition of evidence-based recommendations to adapt surgical approach (open vs laparoscopic vs robotic) and resection techniques to different patient-, tumor-, and surgeon-specific characteristics. To meet the challenges, to overcome the limitations of current kidney cancer literature (such as the retrospective study design, potential risk of biases, and heterogeneous follow-up of most series), and to provide high-quality evidence for future development of effective clinical practice Guidelines, we designed the international REgistry of COnservative or Radical treatment of localized kiDney tumors (i-RECORD) Project. The expected impact of the i-RECORD project is to provide robust evidence on the leading clinical and environmental factors driving selection of the management strategy in patients with kidney cancer, and the differential impact of different management strategies (including AS, WW, AT, PN and RN) on functional, perioperative and oncological outcomes, as well as quality of life assessment, at a mid-long term follow-up (5-10 years).

Official Title

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors (i-RECORd)

Stanford Investigator(s)

Benjamin I. Chung
Benjamin I. Chung

Associate Professor of Urology

Eligibility


Inclusion Criteria:

   - Radiological diagnosis of renal tumor susceptible to active treatment or AS/WW.

   - Age ≥18 years

   - Informed consent signed

Exclusion Criteria:

   - Patient refuse to participate in clinical research.

   - Urothelial renal carcinoma.

Intervention(s):

procedure: Partial Nephrectomy (PN)

procedure: Radical Nephrectomy (RN)

procedure: Ablation therapy (AT)

diagnostic test: Active Surveillance (AS)

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Satvir Basran
sbasran@stanford.edu

New Trial Alerts

Receive email alerts when trials open to patients.